To confirm the safety and efficacy of a low-calorie mayonnaise supplemented with phytosterol esters (PEM) at a daily consumption dose of 884 mg given for 12 weeks with the goal of lowering serum low-density lipoprotein (LDL) cholesterol levels, we conducted a double-blind comparative study in healthy adults with marginally high serum levels of LDL cholesterol and total cholesterol using a mayonnaise without phytosterol esters supplementation (CM) as the control food. Serum LDL cholesterol levels decreased significantly in the PEM group as compared with the CM group during the 12-week intervention period (136.3 ± 16.4 vs. 145.0 ± 19.3 mg/dL at Week 8 (P < 0.05) and 135.0 ± 17.4 mg/dL vs. 144.9 ± 17.5 mg/dL at Week 12; P < 0.05). No observable adverse effects were observed due to the ingestion of PEM in this study. The safety of PEM was again confirmed by an additional clinical study in which healthy adult subjects ingested a 3-fold greater amount of PEM (2,652 mg of phytosterol esters as a daily dose) for 4 weeks. Thus, we concluded that PEM is effective in lowing serum levels of LDL cholesterol and is safe and well tolerated without any clinical problems.
INTRODUCTION
Recent cause-of-death population statistics in Japan reveal that arteriosclerotic disorders, especially cardiovascular diseases (e.g., myocardial infarction) and cerebrovascular diseases (e.g., cerebral infarction and stroke) have become major causes of death, along with malignant neoplasms 1) .
According to a report compiled by the Japan Society of Ningen . There has also been a substantial increase in the number of people with abnormal lipid metabolism, which eventually results in hypercholesterolemia or hyperlipidemia.
Because persons with hyperlipidemia are at high risk for arteriosclerosis (potentially causing myocardial infarction and/ or cerebral infarction 3) ), there is increasing public awareness of the threat of hyperlipidemia as well as related metabolic abnormalities (e.g., obesity and metabolic syndrome).
To prevent the development of hyperlipidemia, serum cholesterol levels should be kept within the normal range by healthy living, although this can be difficult. One potential approach to this goal involves the supplementary use of diet foods containing sufficient amounts of phytosterol esters, which are known to be active in lowering serum cholesterol levels 4, 5) . The serum level of total cholesterol has long been used as the major criterion for evaluating the anti- cholesterol than that of total cholesterol. In the present study, therefore, we chose the LDL cholesterol level as the primary criterion for efficacy evaluation; the serum total cholesterol level was retained as a major efficacy evaluation criterion after LDL cholesterol.
Phytosterol esters, in which a phytosterol molecule binds to a fatty acid molecule to form an ester bond, are contained in a wide variety of natural foods: tiny amounts are present in grains and vegetables, whereas greater amounts are found in rapeseeds, soybeans, broccoli, and bran 6, 7) . After oral intake of phytosterol esters, the ester bond is cleaved to generate free phytosterol in the intestine. There, cholesterol exists in a form of bile acid micelles that permit intestinal absorption. Orally administered phytosterol, whose structure is similar to that of cholesterol, has been shown to be effective in competitively inhibiting the micellization of cholesterol and results in accelerated excretion of unmicellized cholesterol in the feces 5) .
Therefore, it is reasonable to consider that oral phytosterol or its ester could lower serum cholesterol levels by reducing the amount of cholesterol absorbed in the intestinal tract 8, 9) .
Recently, we developed a low-calorie mayonnaise (hereafter referred to as phytosterol ester mayonnaise, abbreviated PEM) supplemented with phytosterol esters (sterol composition of campesterol : stigmasterol : beta-sitosterol in a 1 : 1 : 2, molar ratio; 884 mg per 15 g mayonnaise) using an advanced emulsifying technique. In Japan, many different types of foods that contain emulsified phytosterol supplements or are emulsified phytosterol esters (including those approved as foods for specified health use FOSHU) have been shown to possess an appreciable anti-hypercholesterolemic effect.
Although the inhibition of cholesterol micellization has been reported as a potential mechanism of action of this beneficial effect 5) , the relationship between the emulsification state of such foods and their precise anti-hypercholesterolemic effect remains to be investigated.
We thus sought to confirm the efficacy of this low-calorie mayonnaise (PEM), which contains a basal amount of phytosterol esters corresponding to a daily phytosterol ester intake dose of 884 mg, in lowering serum levels of LDL cholesterol and total cholesterol. We conducted a randomized, . Approval was received from each study site (or from the research ethics committee commissioned by each study site) and written informed consent was obtained from all subjects. The excessive-intake safety study was approved by the Ethical committee of the Yukokai Medical Organization and the efficacy study approved by this Ethical Committee and the Ethical Committee of the Soujinkai Mareesia Garden Clinic.
Efficacy Study
This study was designed as a randomized, double-blind, controlled parallel-group study.
Subjects: Subjects (men and women aged 20-64 years) who had serum levels of 120-180 mg/dL low-density lipoprotein (LDL) cholesterol and 200-240 mg/dL total cholesterol within the screening period were selected as subjects, based on a notification regarding application for review of FOSHU issued by the regulatory authorities 12) . The major exclusion criterion was the regular use of medical drugs or specially designed health foods that can affect serum lipid concentrations and lipid metabolism. All eligible subjects (n = 102) were randomly allocated to the PEM or CM group. The inter-group differences were minimized in terms of gender, age, and baseline serum levels of LDL cholesterol and total cholesterol. Analysis of variance by repetitive determination was performed for "dietary and exercise parameters" and "lipid metabolism parameters" and these date were further analyzed by repeated-measures ANOVA using the Bonferroni correction method.
On the other hand, the unpaired t-test was used for an intergroup comparison between the two study groups, and a paired t-test was used for an intra-group comparison with the baseline of safety evaluation.
Excessive-intake Safety Study
This study was designed as a randomized, double-blind, controlled parallel-group study. Thirty subjects (16 male/14 female) aged 20-64 years with serum LDL-cholesterol levels ranging from 70 to 180 mg/dL were assigned to either PEM or CM group. Subjects were assigned such that each study group was similar with regard to sex, mean age, and mean serum LDL cholesterol level. All subjects were asked to ingest three packs (45 g in total) of either PEM or CM allotted study food daily with meals for 4 weeks. The daily consumption dose of phytosterol esters for individuals in the PEM group was 2,652 mg, and for individuals in the CM group was 96 mg.
Subjective symptoms were self-recorded, and laboratory tests (hematology, blood chemistry, urinalysis), weight, and determination of serum levels of phytosterols and vitamins were performed at the indicated assessment time points.
RESULTS

Efficacy Study
Baseline subject data: Of 102 subjects (PEM group: 51
enrolled, one participant in each study group withdrew from the study within 4 weeks after starting of the intervention. Of the remaining 100 subjects, 20 were excluded from the efficacy evaluation due to the presence of an incompliant lifestyle (14 subjects) or a menstrual period overlapping with two or more laboratory examination days during the pre-intervention and/or intervention period (6 subjects); menstruation is known to affect serum cholesterol levels 13) . The study food compliance rate for each of the remaining 80 individual subjects was ≥ 80%. Baseline characteristics of the 80 eligible subjects are shown in Table 2 . The PEM group comprised 45 subjects (28 men, 17 women), and the CM group 35 subjects (25 men, 10 women). Average ages were 48.8 and 48.9 years, respectively, Table 3 for both study groups. There were no significant differences in any of the dietary or exercise parameters between the two study groups.
However, some significant changes from baseline in the intake quantities of energy, lipids, and sodium as well as exercise level were observed at several assessment time points during the intervention period.
Efficacy evaluation: Data describing lipid metabolism profiles in terms of serum levels of various lipid metabolites, including LDL cholesterol and total cholesterol, for the two study groups over the whole study period are shown in Table 4 .
Changes in serum levels of LDL cholesterol are also illustrated in Fig. 1 In addition, analysis of variance by repetitive determination for both serum levels of LDL cholesterol and total cholesterol at baseline, Week 4, Week 8, and Week 12 in the PEM group yielded a significant difference (P < 0.01). Repeated measurements ANOVA with Bonferroni correction also revealed a significant difference (P < 0.01). In contrast, the analysis of variance by repetitive determination for the CM group did not yield any significant difference.
Pearson's correlation coefficient testing, performed to investigate a possible relationship between the serum levels of LDL cholesterol at baseline and at each of the three assessment points during the intervention period (i.e., Weeks 4, 8, and 12) in both the PEM and CM group, also revealed interesting results. As illustrated in Fig. 2 , the correlation coefficient values (r) for the PEM group were 0.620 (P < 0.001) at Week 12. Significant correlations also seen at Week 4 (0.811, P < 0.001) and at Week 8 (0.676, P < 0.001) (data not shown).
Those for the CM group were: 0.620 (P < 0.001), 0.662 (P < 0.001) and 0.558 (P < 0.01), respectively. As shown in Table 6 , no clinically significant mean changes in body weight, systolic blood pressure, diastolic blood pressure, or pulse rate were observed in either study group. No individual subjects in either study group were considered by the Medical Investigator to have any clinically significant abnormalities. Of the 102 Intend-To-Treat subjects, 17 (33.3%) Table 5 -2 Changes in the mean values of blood chemistry parameters in the two study groups during the study period (2) PEM group: n = 45 (except n = 44 at Week 4), CM group: n = 35 Numbers are mean ± standard deviation. #: P < 0.05 (two sample t test, inter-group comparison) **: P < 0.01, *: P < 0. in the PEM group and 20 (39.2%) in the CM group experienced adverse events during the study period. The most common (≥ 70%) adverse event in both study groups was the common cold. Other adverse events experienced by ≥ 5% of the subjects in both study groups included headache, menorrhalgia, diarrhea, and abdominal pain. All of these events were mild and transient, and no relationship was found between any of these adverse events and the study food ingested. Several lipid metabolism-related laboratory tests were performed before the start and after the end of the 12-week intervention, and the mean values were compared with each other. As shown in Table 7 , campesterol levels in the PEM group increased significantly; those in the CM group decreased significantly, resulting in a significant inter-group difference (P < 0.05). Although vitamin E levels increased significantly in both study groups, the extent of increase was greater for the CM group than the PEM group.
Excessive-intake Safety Study
Fifteen subjects ( . These findings suggest that the . Consistent with that study, the results of the present studies showed that a 12-week intake of 884 mg/day or a 4-week intake of 2,652 mg/day of phytosterol esters in the form of a low-calorie mayonnaise modestly affected the absorption of beta-carotene, vitamin A and vitamin E. Although this issue remains to be clarified, the PEM used in the present studies does not appear to significantly affect the intestinal absorption of fat-soluble vitamins and may be beneficial to those at risk of hypercholesterolemia.
CONCLUSION
We showed that both a low-calorie mayonnaise containing phytosterol esters (daily dose of 886 mg) for 12 weeks and the same type of food containing a three-fold higher amount of phytosterol esters (daily dose of 2,652 mg) ingested for 4 weeks were safe and well tolerated. The former treatment was effective in lowering serum levels of LDL cholesterol and total cholesterol to a significant extent in comparison to the control mayonnaise. 
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